
Patient Advocates Demand Oral Parity in North Carolina
The demand for oral parity for oncology medications is back up for vote in the Senate in North Carolina.
Patient advocacy groups in North Carolina, like ACSCAN, are demanding that the state should implement the oral/infusion cancer drug parity law. While Oregon was the
“It should not matter what method of chemotherapy a cancer patient is receiving, whether it’s an IV infusion or a pill,” said Christine Weason, the North Carolina government relations director for the American Cancer Society Cancer Action Network
Read more in
Watch a panel discussion among payers and healthcare policy experts on the topic that was recently convened by
Read more here: http://www.charlotteobserver.com/living/health-family/article27365617.html#storylink=cpy
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.